Research

With your support, the ALS Society of BC was successful with the launch of PROJECT HOPE, raising in excess of $5.3M to establish an endowed trust to fund an ALS Research Professorship at UBC. As this is an endowed trust, funds for the professorship will be in perpetuity. A clinician-scientist will be recruited to oversee, spearhead, and create opportunities for patients to access clinical trials in BC, to become a leader not only in Canada but the world for ALS research. They will champion enhanced care for ALS patients in BC. 

The ALS Clinic move to UBC is taking place. 

It is our dream to End ALS through creating a world class ALS Centre at UBC. To that end, the ALS Society of BC has pledged to UBC to raise an additional $20M to see this come to fruition.

For more information:
Wendy Toyer, Executive Director
Email: [email protected] | Office (604) 278-2257 ext. 222 | Cell (778) 999-6257

2023 Links:

• UPDATE ON ALS CLINICAL TRIALS
• The Neuro – The Montreal Neurological Institute-Hospital: ALS CURRENT RECRUITING TRIALS

Past Links:

• International Alliance of ALS/MND Associations Briefing Notes – August 2022
  • AB Science Masitinib
  • Amylyx AMX0035
  • Biogen Tofersen
  • MT Pharma Oral Edaravone
• Amylyx Pharmaceuticals Announces ALBRIOZA™ is Now Available in Canada for the Treatment of ALS
• Biogen Wins FDA Priority Review for ALS Therapy
• Health Canada Approves use of  ALBRIOZA
• Project MinE
• Treatment for ALS Patients Endaravone (Radicava)